Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise M Hynes

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Plos Medicine|October 21, 2021
Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort studyGeorge N Ioannou, Jacqueline M Ferguson, Ann M O'Hare, et al.
JAMA Network Open|November 11, 2022
Early Adoption of Anti-SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022Kristina L Bajema, Xiao Qing Wang, Denise M Hynes, et al.
The Lancet. Infectious Diseases|January 23, 2025
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation studyKristina L Bajema, Lei Yan, Yuli Li, et al.
Frontiers in Health Services|September 1, 2023
Understanding care coordination for Veterans with complex care needs: protocol of a multiple-methods study to build evidence for an effectiveness and implementation studyDenise M Hynes, Diana J Govier, Meike Niederhausen, et al.
JAMA Internal Medicine|August 21, 2023
Late Mortality After COVID-19 Infection Among US Veterans vs Risk-Matched Comparators: A 2-Year Cohort AnalysisTheodore J Iwashyna, Sarah Seelye, Theodore S Berkowitz, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Medicine|November 19, 2022
Consensus elements for observational research on COVID-19-related long-term outcomesAndrew J Admon, Pandora L Wander, Theodore J Iwashyna, et al.
JAMA Network Open|April 10, 2024
Risk of Potentially Preventable Hospitalizations After SARS-CoV-2 InfectionDiana J Govier, Meike Niederhausen, Yumie Takata, et al.
JAMA Network Open|March 1, 2024
Self-Reported Everyday Functioning After COVID-19 InfectionTheodore J Iwashyna, Valerie A Smith, Sarah Seelye, et al.
Annals of Internal Medicine|June 5, 2023
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month OutcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Plos Medicine|October 21, 2021
Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort studyGeorge N Ioannou, Jacqueline M Ferguson, Ann M O'Hare, et al.
JAMA Network Open|November 11, 2022
Early Adoption of Anti-SARS-CoV-2 Pharmacotherapies Among US Veterans With Mild to Moderate COVID-19, January and February 2022Kristina L Bajema, Xiao Qing Wang, Denise M Hynes, et al.
The Lancet. Infectious Diseases|January 23, 2025
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation studyKristina L Bajema, Lei Yan, Yuli Li, et al.
Frontiers in Health Services|September 1, 2023
Understanding care coordination for Veterans with complex care needs: protocol of a multiple-methods study to build evidence for an effectiveness and implementation studyDenise M Hynes, Diana J Govier, Meike Niederhausen, et al.
JAMA Internal Medicine|August 21, 2023
Late Mortality After COVID-19 Infection Among US Veterans vs Risk-Matched Comparators: A 2-Year Cohort AnalysisTheodore J Iwashyna, Sarah Seelye, Theodore S Berkowitz, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Medicine|November 19, 2022
Consensus elements for observational research on COVID-19-related long-term outcomesAndrew J Admon, Pandora L Wander, Theodore J Iwashyna, et al.
JAMA Network Open|April 10, 2024
Risk of Potentially Preventable Hospitalizations After SARS-CoV-2 InfectionDiana J Govier, Meike Niederhausen, Yumie Takata, et al.
JAMA Network Open|March 1, 2024
Self-Reported Everyday Functioning After COVID-19 InfectionTheodore J Iwashyna, Valerie A Smith, Sarah Seelye, et al.
Annals of Internal Medicine|June 5, 2023
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month OutcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Pageof 12